inforMED
NKFClass III

Immunohistochemistry Antibody Assay, C-kit

Hematology · 21 CFR 864.1860

Identification/Intended Use - The anti-c-KIT primary antibody is intended for laboratory use, via light microscopy, for the qualitative detection of KIT protein in formalin-fixed, paraffin-embedded gastrointestinal stromal tumors (GISTs) using either an automated immunohistochemistry staining system or manual assay. It is indicated as an aid in the selection of GIST patients who may qualify for imatinib mesylate therapy within the context of the patient's clinical history, tumor morphology, and other diagnostic tests evaluated by a qualified pathologist. The test is not intended as the sole basis for making the diagnosis of GIST and is not intended as the sole basis for selecting imatinib mesylate therapy. A negative result would not necessarily exclude the diagnosis of GIST

MDR events0All time
Recalls1All time
Registered firms2Currently listed
510(k) clearances0All time

Recent MDR events

0 adverse event reports on file

See all →

No MDR events on file for this product code.

Event type breakdown

No data available.

Most-reported manufacturers

See all →

No data available.

Registered firms

2 firms currently registered for this product code

See all →

510(k) clearances

0 clearances for this product code

See all →

No 510(k) clearances on file for this product code.